Evidence map›Paper›PMID 35509437›Full record

ArticleERJ open research2022

An externally validated fully automated deep learning algorithm to classify COVID-19 and other pneumonias on chest computed tomography.

Akshayaa Vaidyanathan, Julien Guiot, Fadila Zerka, Flore Belmans, Ingrid Van Peufflik, Louis Deprez, Denis Danthine, Gregory Canivet, Philippe Lambin, Sean Walsh and 5 more

Abstract read
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Akshayaa VaidyanathanRadiomics (Oncoradiomics SA), Liège, Belgium.ORCID https://orcid.org/0000-0001-8012-6516
Julien GuiotDept of Pneumology, University Hospital of Liège, Liège, Belgium.ORCID https://orcid.org/0000-0001-7800-1730
Fadila ZerkaRadiomics (Oncoradiomics SA), Liège, Belgium.
Flore BelmansRadiomics (Oncoradiomics SA), Liège, Belgium.
Ingrid Van PeufflikRadiomics (Oncoradiomics SA), Liège, Belgium.
Louis DeprezDept of Radiology, University Hospital of Liège, Liège, Belgium.
Denis DanthineDept of Radiology, University Hospital of Liège, Liège, Belgium.
Gregory CanivetDept of Computer Applications, University Hospital of Liège, Liège, Belgium.
Philippe LambinThe D-Lab, Depts of Precision Medicine, and Radiology and Nuclear Medicine, GROW-School for Oncology, Maastricht University, Maastricht, The Netherlands.ORCID https://orcid.org/0000-0001-7961-0191
Sean WalshRadiomics (Oncoradiomics SA), Liège, Belgium.
Mariaelena OcchipintiRadiomics (Oncoradiomics SA), Liège, Belgium.
Paul MeunierDept of Radiology, University Hospital of Liège, Liège, Belgium.
Wim VosRadiomics (Oncoradiomics SA), Liège, Belgium.
Pierre LovinfosseDept of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
Ralph T H LeijenaarRadiomics (Oncoradiomics SA), Liège, Belgium.ORCID https://orcid.org/0000-0001-8642-9657

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: In this study, we propose an artificial intelligence (AI) framework based on three-dimensional convolutional neural networks to classify computed tomography (CT) scans of patients with coronavirus disease 2019 (COVID-19), influenza/community-acquired pneumonia (CAP), and no infection, after automatic segmentation of the lungs and lung abnormalities. Methods: The AI classification model is based on inflated three-dimensional Inception architecture and was trained and validated on retrospective data of CT images of 667 adult patients (no infection n=188, COVID-19 n=230, influenza/CAP n=249) and 210 adult patients (no infection n=70, COVID-19 n=70, influenza/CAP n=70), respectively. The model's performance was independently evaluated on an internal test set of 273 adult patients (no infection n=55, COVID-19 n= 94, influenza/CAP n=124) and an external validation set from a different centre (305 adult patients: COVID-19 n=169, no infection n=76, influenza/CAP n=60). Results: The model showed excellent performance in the external validation set with area under the curve of 0.90, 0.92 and 0.92 for COVID-19, influenza/CAP and no infection, respectively. The selection of the input slices based on automatic segmentation of the abnormalities in the lung reduces analysis time (56 s per scan) and computational burden of the model. The Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) score of the proposed model is 47% (15 out of 32 TRIPOD items). Conclusion: This AI solution provides rapid and accurate diagnosis in patients suspected of COVID-19 infection and influenza.

Identifiers

PMID35509437
PMCPMC8958945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.